BIO-key International, Inc.

BIO-key International, Inc. is a global provider of Identity and Access Management (IAM) and biometric authentication solutions. The company's core mission is to revolutionize authentication and cybersecurity by offering secure, convenient, and user-friendly authentication methods, aiming to move beyond traditional passwords and hardware tokens. Headquartered in Holmdel, New Jersey, USA, BIO-key focuses on empowering organizations with robust identity solutions.

BIO-key's product portfolio includes the PortalGuard IAM platform and PortalGuard IDaaS (Identity-as-a-Service), which provide single sign-on, multi-factor authentication, and self-service password reset capabilities. They also offer WEB-key for biometric civil and large-scale ID infrastructure, and the MobileAuth mobile authentication application. The company develops and markets related hardware, such as fingerprint scanners and FIDO-compliant devices. Their solutions, which emphasize biometric-centric, multi-factor authentication and Identity-Bound Biometrics (IBB), serve diverse market segments including commercial, government, education, financial services, healthcare, manufacturing, and retail.

Michael W. DePasquale serves as the Chairman and Chief Executive Officer of BIO-key International, a position he has held since January 2003. In recent corporate developments, BIO-key International, Inc. executed a 1-for-10 reverse stock split on April 30, 2026, to regain compliance with Nasdaq's minimum bid price requirement. The company also announced a strategic partnership with TD SYNNEX Public Sector (DLT Solutions) in March 2026, aimed at expanding its security solutions to U.S. federal, state, and local government agencies. BIO-key anticipates a 50% increase in first-half 2026 revenues, driven by growing software license momentum and hardware sales.